Ozempic, Wegovy, Mounjaro, and Saxenda – from Hollywood to high street pharmacies, they are everywhere. These are the weight loss drugs that have been hailed as a “ miracle ” and the “ wonder drug [s] ...
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
19h
Hosted on MSNThyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?Fact checked by Nick Blackmer Weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results